Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is UBROGEPANT, with a corresponding US DMF Number 38648.
Remarkably, this DMF maintains an Active status since its submission on August 11, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 26, 2023, and payment made on August 09, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II